These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 23179729)
1. Outcomes of salvage prostate cryotherapy stratified by pre-treatment PSA: update from the COLD registry. Spiess PE; Levy DA; Pisters LL; Mouraviev V; Jones JS World J Urol; 2013 Dec; 31(6):1321-5. PubMed ID: 23179729 [TBL] [Abstract][Full Text] [Related]
2. Predictors of biochemical failure in patients undergoing prostate whole-gland salvage cryotherapy: a novel risk stratification model. Spiess PE; Levy DA; Mouraviev V; Pisters LL; Jones JS BJU Int; 2013 Aug; 112(4):E256-61. PubMed ID: 23469778 [TBL] [Abstract][Full Text] [Related]
3. Achieving the 'bifecta' using salvage cryotherapy for locally recurrent prostate cancer: analysis of the Cryo On-Line Data (COLD) registry data. Spiess PE; Given RW; Jones JS BJU Int; 2012 Jul; 110(2):217-20. PubMed ID: 21992443 [TBL] [Abstract][Full Text] [Related]
4. Five-Year Biochemical Progression-Free Survival Following Salvage Whole-Gland Prostate Cryoablation: Defining Success with Nadir Prostate-Specific Antigen. Kovac E; ElShafei A; Tay KJ; Mendez M; Polascik TJ; Jones JS J Endourol; 2016 Jun; 30(6):624-31. PubMed ID: 26915721 [TBL] [Abstract][Full Text] [Related]
5. Prostate Specific Antigen Nadir of 0.1 or Less Is a Predictor of Treatment Success in Men Undergoing Salvage Whole Prostate Gland Cryoablation. Nyame YA; Elshafei A; Greene DJ; Arora HC; Given RW; Tay KJ; Polascik TJ; Ross AE; Mouraviev VB; Lugnani F; Jones JS J Endourol; 2017 May; 31(5):497-501. PubMed ID: 28437170 [TBL] [Abstract][Full Text] [Related]
6. Presalvage prostate-specific antigen (PSA) and PSA doubling time as predictors of biochemical failure of salvage cryotherapy in patients with locally recurrent prostate cancer after radiotherapy. Spiess PE; Lee AK; Leibovici D; Wang X; Do KA; Pisters LL Cancer; 2006 Jul; 107(2):275-80. PubMed ID: 16770783 [TBL] [Abstract][Full Text] [Related]
7. Single center experience with third-generation cryosurgery for management of organ-confined prostate cancer: critical evaluation of short-term outcomes, complications, and patient quality of life. Hubosky SG; Fabrizio MD; Schellhammer PF; Barone BB; Tepera CM; Given RW J Endourol; 2007 Dec; 21(12):1521-31. PubMed ID: 18186694 [TBL] [Abstract][Full Text] [Related]
8. Salvage focal prostate cryoablation for locally recurrent prostate cancer after radiotherapy: initial results from the cryo on-line data registry. Li YH; Elshafei A; Agarwal G; Ruckle H; Powsang J; Jones JS Prostate; 2015 Jan; 75(1):1-7. PubMed ID: 25283814 [TBL] [Abstract][Full Text] [Related]
9. Salvage Cryoablation for Radiorecurrent Prostate Cancer: Initial Experience at a Regional Health Care System. Safavy S; Jabaji RB; Lu SM; Slezak JM; Cosmatos HA; Williams SG; Finley DS Perm J; 2019; 23():. PubMed ID: 31050644 [TBL] [Abstract][Full Text] [Related]
10. Salvage cryosurgery for recurrent prostate cancer after radiation therapy: a seven-year follow-up. Bahn DK; Lee F; Silverman P; Bahn E; Badalament R; Kumar A; Greski J; Rewcastle JC Clin Prostate Cancer; 2003 Sep; 2(2):111-4. PubMed ID: 15040872 [TBL] [Abstract][Full Text] [Related]
11. Salvage prostate cryoablation: initial results from the cryo on-line data registry. Pisters LL; Rewcastle JC; Donnelly BJ; Lugnani FM; Katz AE; Jones JS J Urol; 2008 Aug; 180(2):559-63; discussion 563-4. PubMed ID: 18554664 [TBL] [Abstract][Full Text] [Related]
12. Salvage cryoablation of the prostate: followup and analysis of predictive factors for outcome. Ng CK; Moussa M; Downey DB; Chin JL J Urol; 2007 Oct; 178(4 Pt 1):1253-7; discussion 1257. PubMed ID: 17698104 [TBL] [Abstract][Full Text] [Related]
13. Comparison of Outcomes Between Preoperatively Potent Men Treated with Focal Versus Whole Gland Cryotherapy in a Matched Population. Mendez MH; Passoni NM; Pow-Sang J; Jones JS; Polascik TJ J Endourol; 2015 Oct; 29(10):1193-8. PubMed ID: 26058496 [TBL] [Abstract][Full Text] [Related]
14. Salvage cryoablation for local recurrence of prostatic cancer after curative therapy. Barat M; Colleter L; Mongiat-Artus P; Jolibois Z; Quero L; Hennequin C; Desgrandchamps F; de Kerviler E Diagn Interv Imaging; 2019 Nov; 100(11):679-687. PubMed ID: 31331832 [TBL] [Abstract][Full Text] [Related]
15. Cryoablation for clinically localized prostate cancer using an argon-based system: complication rates and biochemical recurrence. De La Taille A; Benson MC; Bagiella E; Burchardt M; Shabsigh A; Olsson CA; Katz AE BJU Int; 2000 Feb; 85(3):281-6. PubMed ID: 10671882 [TBL] [Abstract][Full Text] [Related]
16. Disease-free survival following salvage cryotherapy for biopsy-proven radio-recurrent prostate cancer. Williams AK; Martínez CH; Lu C; Ng CK; Pautler SE; Chin JL Eur Urol; 2011 Sep; 60(3):405-10. PubMed ID: 21185115 [TBL] [Abstract][Full Text] [Related]
17. Avoidance of androgen deprivation therapy in radiorecurrent prostate cancer as a clinically meaningful endpoint for salvage cryoablation. Ginsburg KB; Elshafei A; Yu C; Jones JS; Cher ML Prostate; 2017 Oct; 77(14):1446-1450. PubMed ID: 28856702 [TBL] [Abstract][Full Text] [Related]
18. [Salvage cryotherapy of prostate cancer after failed external radiotherapy and brachytherapy: Morbidity and mid-term oncological results]. Gevorgyan A; Hétet JF; Robert M; Duchattelle-Dussaule V; Corno L; Boulay I; Baumert H Prog Urol; 2018 Apr; 28(5):291-301. PubMed ID: 29551263 [TBL] [Abstract][Full Text] [Related]
19. Salvage cryosurgery for locally recurrent prostate cancer after primary cryotherapy. Chang X; Liu T; Zhang F; Zhao X; Ji C; Yang R; Gan W; Zhang G; Li X; Guo H Int Urol Nephrol; 2015 Feb; 47(2):301-5. PubMed ID: 25510358 [TBL] [Abstract][Full Text] [Related]
20. Salvage cryotherapy with third-generation technology for locally recurrent prostate cancer after radiation therapy. Lian H; Yang R; Lin T; Wang W; Zhang G; Guo H Int Urol Nephrol; 2016 Sep; 48(9):1461-6. PubMed ID: 27300004 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]